ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.296,46
1,21%
S&P 500
6.049,24
0,88%
Dow Jones
44.025,81
1,24%
Euro vs US Dollar
1,04558
0,48%
Bitcoin
104.796,69
-1,30%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. IO Biotech Inc (IOBT) Börsenkurse

IO Biotech Inc

IO Biotech Inc (IOBT)

NASDAQ
0,8718
0,0352
(4,21%)
Geschlossen 22 Januar 10:00PM
Verzögert um 15 Minuten
0,8718
0,00
( 0,00% )
Vor Marktöffnung: 10:02AM
Verzögert um 15 Minuten

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
0,8718
Gebot
0,8319
Fragen
0,92
Volumen
-
0,00 Tagesbereich 0,00
0,66 52-Wochen-Bereich 1,89
Marktkapitalisierung
57,435M
Handelsende
0,8718
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
402.148
Ausgegebene Aktien
65.880.914
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,67
Gewinn pro Aktie (EPS)
-1,31
Erlöse
-
Nettogewinn
-86,08M

Über IO Biotech Inc

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced imm... IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.iobiotech.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
IO Biotech Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker IOBT. The last closing price for IO Biotech was US$0,87. Over the last year, IO Biotech shares have traded in a share price range of US$ 0,66 to US$ 1,89.

IO Biotech currently has 65.880.914 shares in issue. The market capitalisation of IO Biotech is US$57,43 million. IO Biotech has a price to earnings ratio (PE ratio) of -0.67.

IOBT Neueste Nachrichten

Weitere Nachrichten

IO Biotech Completes Enrollment in Phase 2 Trial of its Investigational, Off-the-shelf Therapeutic Cancer Vaccine, IO102-IO103, as Neoadjuvant/Adjuvant Treatment for Patients with Resectable Melanoma or Head and Neck Cancer

-- Enrollment Completed Ahead of Schedule --       -- Initial Data Expected in 2025 -- NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical...

09 Januar 2025
GlobeNewswire Inc.

Form 8-K - Current report

27 Dezember 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

26 Dezember 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

24 Dezember 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

24 Dezember 2024
Edgar (US Regulatory)

Form 8-K - Current report

20 Dezember 2024
Edgar (US Regulatory)

IO Biotech secures up to €57.5 million in debt financing from the European Investment Bank

Funds expected to be used to advance IO Biotech’s immune-modulating therapeutic cancer vaccines, including potential BLA submission for IO102-IO103 in 2025Commitment is part of the European...

20 Dezember 2024
GlobeNewswire Inc.

Form 8-K - Current report

16 Dezember 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

12 November 2024
Edgar (US Regulatory)

Form 8-K - Current report

12 November 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.04375.277140441980.82810.87870.7731178920.82898913CS
4-0.0682-7.255319148940.941.060.7731734900.90739385CS
12-0.4182-32.41860465121.291.360.664021480.85112307CS
26-0.7582-46.51533742331.631.730.663895150.98112663CS
52-0.9382-51.83425414361.811.890.662608171.11375014CS
156-5.4982-86.31397174256.379.770.661463541.62867792CS
260-15.1282-94.551251617.880.661473652.31028848CS

IOBT - Frequently Asked Questions (FAQ)

What is the current IO Biotech share price?
The current share price of IO Biotech is US$ 0,8718
How many IO Biotech shares are in issue?
IO Biotech has 65.880.914 shares in issue
What is the market cap of IO Biotech?
The market capitalisation of IO Biotech is USD 57,43M
What is the 1 year trading range for IO Biotech share price?
IO Biotech has traded in the range of US$ 0,66 to US$ 1,89 during the past year
What is the PE ratio of IO Biotech?
The price to earnings ratio of IO Biotech is -0,67
What is the reporting currency for IO Biotech?
IO Biotech reports financial results in USD
What is the latest annual profit for IO Biotech?
The latest annual profit of IO Biotech is USD -86,08M
What is the registered address of IO Biotech?
The registered address for IO Biotech is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the IO Biotech website address?
The website address for IO Biotech is www.iobiotech.com
Which industry sector does IO Biotech operate in?
IO Biotech operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ASSTAsset Entities Inc
US$ 1,63
(81,11%)
26,58M
BBGIBeasley Broadcast Group Inc
US$ 13,93
(62,92%)
233
IROHIron Horse Acquisition Corporation
US$ 16,44
(58,99%)
14
CRWSCrown Crafts Inc
US$ 7,00
(55,38%)
168
FUSBFirst US Bancshares Inc
US$ 19,99
(53,89%)
8
ABLAbacus Life Inc
US$ 3,01
(-59,97%)
33
STFSStar Fashion Culture Holdings Ltd
US$ 7,36
(-45,52%)
67,73k
RMBIRichmond Mutual Bancorporation Inc
US$ 8,01
(-40,31%)
1
IZTCInvizyne Technologies Inc
US$ 7,02
(-37,88%)
15
GLACGlobal Lights Acquisition Corporation
US$ 7,30
(-31,78%)
6
ASSTAsset Entities Inc
US$ 1,63
(81,11%)
26,58M
IPAImmunoPrecise Antibodies Ltd
US$ 0,6091
(23,55%)
20,06M
RIMEAlgorhythm Holdings Inc
US$ 0,0373
(7,80%)
12,11M
CDIOCardio Diagnostics Holdings Inc
US$ 0,7164
(17,83%)
10,81M
USEGUS Energy Corp
US$ 5,27
(39,05%)
6,35M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
IOBT
IO Biotech
TG
R3NK
RENK
TG
CEA
Friwo
BIT
SEB
Sebino
USOTC
NCKAF
Nickel Asia (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten